The BD MAXâ„¢ Enteric Bacterial Panel Receives FDA Clearance to Detect the Most Common Causes of Bacterial Gastroenteritis

[PR Newswire] – SPARKS, Md., May 7, 2014 /PRNewswire/ — BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared … more

View todays social media effects on BDX

View the latest stocks trending across Twitter. Click to view dashboard

See who Becton is hiring next, click here to view